| Export | Generic pharmaceuticals and nutraceuticals exported primarily to African and Southeast Asian countries. | FDA approval and strategic registrations in emerging markets support competitive edge. | B2B pharmaceutical distributors and healthcare providers in targeted export markets. | Proprietary nutraceutical syrups and specialized generic tablets. | 21 | 87 | Product sales to international distributors and partners. | Direct sales, contract manufacturing agreements. | Market approvals, growing demand in Africa and Asia, and expansion of product registrations. | |
| Domestic | Generic and nutraceutical pharmaceutical products marketed within India. | Strong production capabilities and compliance with local regulatory standards. | B2B and B2C channels including medical stores and clinics. | Branded nutraceutical products and specialized tablets. | 3 | 13 | Direct sales to pharmacies, hospitals, and retailers. | Direct sales with trade discounts. | Growing healthcare expenditure and increasing awareness of nutraceuticals. | |
